A study on relationship between fasting plasma glucose, copper and ceruloplasmin levels in type 2 diabetes mellitus.
MATERIALS AND METHODS: The study group consisted of a total 100 subjects which included non-diabetic healthy control subjects (n=50) and diabetic patients (n=50). Informed consent was taken from all subjects involved in the study and study was approved by institutional ethics committee. Cases with any clinical evidence of retinopathy, nephropathy, neuropathy, coronary heart disease, hypertension, on antioxidant medication were excluded from the study. The controls were not on any medication or dietary restrictions. Fasting samples were collected under sterile measures and used for analysis of parameters. FPG was determined using modified glucose oxidase-peroxidase method. (8) Serum copper using BCDS, (9) ceruloplasmin using PPD. (10) Normal reference ranges of FPG is 70-110mg/dl, copper is 70-140pg/dl, and ceruloplasmin is 20-60mg/dl. Statistical analysis was done using SPSS version 17statistical software package and Unpaired 't' test. Results expressed as mean [+ or -] SD. p- value<0.05 was considered as statistically significant.
RESULTS AND DISCUSSION: Results shows increase in levels of copper and FPG (P<0.001) and decrease in ceruloplasmin (P<0.001) in type 2 DM compared to healthy controls. Copper a transition metal is present in many tissues like liver, muscle etc., It is involved in functioning of enzymes like ceruloplasmin, cytochrome oxidase, tyrosinase, superoxide dismutase, iron absorption process, HDL synthesis. It can oxidize proteins and lipids which lead to increased production of free radical compounds. Ceruloplasmin an alpha 2 globulin is an acute phase copper containing plasma protein synthesized mainly by hepatic parenchymal cells, lymphocytes etc., Hyperglycemia in diabetes mellitus may lead to increased oxidative stress thus leading to increase in transition metals like copper released from its storage site. Copper in its free form is a potent cytotoxic element because of its redox chemistry it readily participates in Fenton and Heiber-Weiss reactions to generate ROS which leads to increased consumption of available antioxidants in the body.
CONCLUSION: To conclude our study shows there is increased serum copper and fasting glucose with decreased ceruloplasmin levels in type 2 DM. Major limitation of the study is the sample size. Study with larger group may be required for further evaluation.
(1.) Kahn SE. The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetol 2003; 46: 3-19 pg.
(2.) Hancock JT, Desican R, Neill SJ. Role of reactive oxygen species in cell signaling pathways. BiochemSoc Trans 2001; 29: 345-50 pg.
(3.) Pi J, Bai Y, Zhang O, Wong V, Floering LM, Daniel K, Reece JM, Deeney JT, Anderson ME, Corkey BE, Collins S. Reactive oxygen species as a signal in glucose stimulated insulin secretion. Diabetes 2007; 56: 1783-91 pg.
(4.) Shetty JK, Prakash M, Ibrahim MS. Relationship between free iron and glycated hemoglobin in uncontrolled type 2 diabetes patients associated with complications. Ind J ClinBiochem 2008; 23(1): 67-70 pg.
(5.) Cunningham J, Leffell M, Mearkle P, Harmatz P. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complication. Metabolism 1995; 44(8): 996-9 pg.
(6.) Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endo Rev 2002; 23: 599-622 pg.
(7.) A Sarkar, S Dash, B K Barik et al, Copper And Ceruloplasmin Levels in Relation to Total Thiols and GST in Type 2 Diabetes Mellitus Patients.Indian Journal of Clinical Biochemistry, 2010; 25(1): 74-76 pg.
(8.) Trinder, P. Ann. Clin., Biochem. 1969; 6: 24 pg.
(9.) Prakash M, Shetty JK. A modified spectrophotometric micromethod to determine serum copper. Asian J Biochem 2008; 3(1): 38-42 pg.
(10.) Ravin HA. An improved colorimetric enzymatic assay of Ceruloplasmin. J Lab Clin Med 1961; 58: 161-8 pg.
Rangaswamy R , Santosh R. G 
[1.] Rangaswamy R.
[2.] Santosh R. G.
PARTICULARS OF CONTRIBUTORS:
[1.] Assistant Professor, Department of Biochemistry, Koppal Institute of Medical Sciences, Koppal, Karnataka.
[2.] Assistant Professor, Department of Medicine, Kannur Medical College, Kannur, Kerala.
FINANCIAL OR OTHER COMPETING INTERESTS: None
NAME ADDRESS EMAIL ID OF THE CORRESPONDING AUTHOR:
Dr. Rangaswamy R, Assistant Professor, Department of Biochemistry, Koppal Institute of Medical Sciences, Koppal, Karnataka.
Date of Submission: 06/07/2015.
Date of Peer Review: 07/07/2015.
Date of Acceptance: 20/07/2015.
Date of Publishing: 19/08/2015.
Table 1: Comparison of various parameters between cases and controls Parameter Controls Fasting plasma glucose (mg/dl) 76.77 [+ or -] 6.56 Copper ([micro]g/dl) 109.56 [+ or -] 16.68 Ceruloplasmin (mg/dl) 34.16 [+ or -] 4.12 Parameter Cases p-value Fasting plasma glucose (mg/dl) 164.14 [+ or -] 19.10 0.0001 Copper ([micro]g/dl) 176.44 [+ or -] 13.67 0.0001 Ceruloplasmin (mg/dl) 15.58 [+ or -] 4.06 0.0001
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||ORIGINAL ARTICLE|
|Author:||Rangaswamy, R.; Santosh, R.G.|
|Publication:||Journal of Evolution of Medical and Dental Sciences|
|Date:||Aug 20, 2015|
|Previous Article:||A study on pattern of skin diseases among children presenting to RIMS, Kadapa, A. P.|
|Next Article:||A rare case of accessory metatarsal without polydactyly a case report with review of literature.|